| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Computers and Technology > Computers and Technology > Artificial Intelligence - Where Are We Today? |
|
Answers - Artificial Intelligence - Where Are We Today?
Indeed, we hear a lot about Artificial Intelligence these days, but few people really understand what artificial intelligence really is. Even more confusing According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product to newcomers and novices is that many folks that are in the artificial intelligence field debate its definition. Still compounding the issue is when commer ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ial ventures begin touting their technologies as artificially intelligent driven, when actually they are not. There are a couple of different categories th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. at those in the field of artificial intelligence fall into. One is those who believe that artificial intelligence is computer software which mimics human de here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ision making or appears to mimic human decision making. Then there is the group that calls themselves purists who believe that neural network processing is d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rue artificial intelligence. Of course we will be discussing both types. We will also touch upon all the different applications, technologies which are or a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ppear to be similar enough, that their creators or marketers have labeled as artificial intelligence. Today we most commonly find that such applications as easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi search engines on the Internet, autonomous operation and interactive eLearning systems, as well as recognition software for speech, facial features, finger nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rints, spell checkers, voice, anti-spam programs or algorithms which scan databases to find anomalies. Of course the more intense the application for instan and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ce self-driving cars, self-piloted planes, corporate telephone systems, weather prediction, stock trading, military net-centric warfare, automated warehousi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi g or computer space systems the more important artificial intelligence becomes. It should be relatively easy to see that artificial intelligence has change ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a our lives as much as computers themselves and in the future even more still with artificially intelligent robotic androids in our homes and decision making dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod computers at work. In the future we will have artificial intelligence running our government, transportation systems, money flows, environment, distributio cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin systems, virtual reality entertainment systems and just about everything you could possibly dream up. Perhaps after reading this book you may in fact think tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen of more applications in your industry? Is the sky the limit to artificial intelligence? Indeed, it does appear to be and yet perhaps not, as we are already t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel using AI underwater and underground, therefore the sky is not the limit and neither is the ground or anything else in this dimension. Artificial intelligen ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e is not even limited to time, space, energy or matter in a single dimension. In the future humans may have add-on features where man and machine is merged y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sing Artificially Intelligent components. So when we examine where we are today with Artificial Intelligent Systems the answer most appropriate would be; . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de m>We are at the Tip of the Ice Berg. The more pressing question is how shall we proceed? Does mankind have the discipline and integrity to continue th elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip forward progression of this technology without sacrificing or risking all we are and all we have built; perhaps that indeed is the greatest question of all tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Looking To Start A Home Based Business On The Internet? Dog Friendly Chicago Apartments Stay At Home Jobs - Get Motivated And Stay Motivated!
|